TITLE

Fixation Time and HER2/neu Assessment

AUTHOR(S)
Bohn, Olga L.; Sanchez-Sosa, Sergio
PUB. DATE
June 2011
SOURCE
American Journal of Clinical Pathology;Jun2011, Vol. 135 Issue 6, p979
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to the article "Fixation Time Does Not Affect Expression of HER2/Neu: A Pilot Study," by J. A. Ibarra and colleagues in the 2010 issue.
ACCESSION #
70108862

 

Related Articles

  • Fixation Time and HER2/neu Assessment. Ibarra, Julio A.; Rogers, Lowell W. // American Journal of Clinical Pathology;Jun2011, Vol. 135 Issue 6, p980 

    A response by J. A. Ibarra and colleagues to a letter to the editor about their article "Fixation Time Does Not Affect Expression of HER2/Neu: A Pilot Study" in the 2010 issue is presented.

  • Construction of Yeast Recombinant Expression Vector Containing Human Epidermal Growth Factor (hEGF). Mohammadian, Jamal; Mansoori-Derakhshan, Sima; Mohammadian, Masood; Shekari-Khaniani, Mahmoud // Advanced Pharmaceutical Bulletin;Jun2013, Vol. 3 Issue 2, p473 

    Purpose: The objective of this study was construction of recombinant hEGF-pPIC9 which may be used for expression of recombinant hEGF in following studies. Methods: EGF cDNA was purchased from Genecopoeia Company and used for PCR amplification. Prior to ligation, the PCR product and pPIC9 vector...

  • A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes. Dutta, B; Pusztai, L; Qi, Y; André, F; Lazar, V; Bianchini, G; Ueno, N; Agarwal, R; Wang, B; Shiang, C Y; Hortobagyi, G N; Mills, G B; Symmans, W F; Balázsi, G // British Journal of Cancer;3/13/2012, Vol. 106 Issue 6, p1107 

    Background:The rapid collection of diverse genome-scale data raises the urgent need to integrate and utilise these resources for biological discovery or biomedical applications. For example, diverse transcriptomic and gene copy number variation data are currently collected for various cancers,...

  • Serum follicle-stimulating hormone level is associated with human epidermal growth factor receptor type 2 and Ki67 expression in post-menopausal females with breast cancer. JUN ZHOU; YIDING CHEN; YITING HUANG; JINPEI LONG; FANG WAN; SUZHAN ZHANG // Oncology Letters;2013, Vol. 6 Issue 4, p1128 

    The present study aimed to determine the association between levels of the gender hormones, follicle-stimulating hormone (FSH), luteinizing hormone (LH), progesterone (P) and prolactin (PRL), and two breast cancer molecular markers, human epidermal growth factor receptor 2 (Her-2) and Ki67, in...

  • Quantitative Analysis of HER2 Receptor Expression In Vivo by Near-Infrared Optical Imaging. Chernomordik, Victor; Hassan, Moinuddin; Sang Bong Lee; Zielinski, Rafal; Gandjbakhche, Amir; Capala, Jacek // Molecular Imaging;Jul/Aug2010, Vol. 9 Issue 4, p192 

    Human epidermal growth factor receptor 2 (HER2) overexpression in breast cancers is associated with poor prognosis and resistance to therapy. Current techniques for estimating this important characteristic use ex vivo assays that require tissue biopsies. We suggest a novel noninvasive method to...

  • A Mathematical Model for the Effects of HER2 Over-Expression on Cell Cycle Progression in Breast Cancer. Eladdadi, Amina; Isaacson, David // Bulletin of Mathematical Biology;Dec2011, Vol. 73 Issue 12, p2865 

    In this paper, we present a mathematical model predicting the fraction of proliferating cells in G1, S, and G2/M phases of the cell cycle as a function of EGFR and HER2. We show that it is possible to find parameters for the mathematical model so that its predictions agree with the experimental...

  • Expresión de los receptores hormonales (RB/RP) y sobreexpresión de la proteína HER-2/neu en carcinoma ductal infiltrante. Anteliz B., Olga T.; Ayala, Jaime O.; Garcia, Carlos A.; Valencia, Laura I.; Alvarez O., Olga M. // Revista Salud UIS;2011, Vol. 43 Issue 2, p149 

    Introduction: The degree of tumor differentiation, the expression of estrogen and progesterone receptors and HER-2/ neu protein overexpressing are important prognostic and predictive factors in the evolution and therapeutic management of invasive breast carcinoma. In different studies were found...

  • Examination of p53 and c-erbB-2 Expression.  // Fertility Weekly;4/21/2003, p6 

    Examines the different patterns of p53 and c-erbB-2 expression in ovarian endometrioid carcinomas arising in endometriosis and ovarian endometrioid carcinomas. Characterization of ovarian endometrioid tumors; Role of the somatic alterations in candidate tumor suppressor genes in the development...

  • Expression Patterns of ER, HER2, and NM23-H1 in Breast Cancer Patients with Different Menopausal Status. Su-Wei Dong; Lin Wang; Jun Sui; Xi-Yun Deng; Xiao-Dan Chen; Zhi-Wei Zhang; Xu Liu; Zhi-Min Liu; Jian-Hua Zhang; Qi-Sheng Yang; Yong-Feng Jia; Xin Song // Molecular Diagnosis & Therapy;Jul2011, Vol. 15 Issue 4, p211 

    Objective: This study was designed to analyze expression patterns of estrogen receptor (ER), human epidermal growth factor receptor-2 (HER2/ERBB2), and nonmetastatic protein 23 (NM23-H1/NME1) proteins in patients with invasive ductal carcinoma and different menopausal status to identify their...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics